Nor is there, as shown here, any clear-cut border between lipoma and WDLS with regard to HMGA2 status or MDM2 CN level or expression levels of these two genes, providing molecular support for the existence of an intermediary tumor type. The gene discussed is HMGA2; the disease is well-differentiated liposarcoma.